Dr. Robert Bard Appointed Chair of Clinical Diagnostics at MBCGA

MEDICAL DIAGNOSTIC TRAILBLAZER IS THE NEXT MUSCLE IN MALE BREAST CANCER ADVOCACY

5-24-2025 / New York, NY — In a groundbreaking move that signals a powerful step forward in the fight against male breast cancer, the Male Breast Cancer Global Alliance (MBCGA) has announced the appointment of Dr. Robert Bard as Committee Chair of Clinical Diagnostics. A visionary in medical imaging and an internationally recognized advocate for integrative cancer care, Dr. Bard brings decades of experience and innovation to a role designed to unify health professionals and elevate awareness around this often-overlooked disease.

Dr. Bard’s new role is not merely ceremonial—it marks the official launch of a clinical diagnostics branch within MBCGA. This division aims to centralize diagnostic expertise, standardize early detection methods, and serve as an educational hub for medical professionals worldwide. For MBCGA co-founder Cheri Ambrose, the appointment represents “the highest task”—entrusting a leader who can connect radiologists, oncologists, and integrative medicine experts in a cause that has lacked unified attention for too long.

FROM ADVOCACY TO ACTION: A RETROSPECTIVE
“Dr. Bard has always been a driving force behind male breast cancer advocacy,” said Ambrose. “But this is the first time we’ve had the opportunity to make a tangible, global impact together. His networks and experience make him the perfect figure to lead this mission.”

With an over 10-year partnership already established between Dr. Bard and Male Breast Cancer advocates, this appointment feels like a natural evolution. Bard has long been a prominent advocate for bringing underrepresented cancers into the spotlight, especially those affecting male populations. His leadership comes at a time when the push for equity in cancer diagnostics and treatment is gaining critical momentum.

Currently a fellow of both the American Society for Lasers in Medicine and Surgery and the American Institute of Ultrasound in Medicine, Dr. Bard also serves in advisory roles for several national organizations including the ‘Are You Dense?’ Foundation, F.A.C.E.S. (National Firefighters Against Cancers & Exposures), the Women’s Health Collaborative, and the American Breast Cancer Foundation. His involvement extends to the Executive Board of the New York Arthritis Foundation and leadership in the Integrative Health Research Center.

Beyond his clinical practice in Manhattan, Dr. Bard is the founder of the AngioFoundation, a nonprofit focused on advanced diagnostic imaging. Through this organization, he launched UNCOVERED, the official newsletter for male breast cancer. The publication is not only an advocacy tool—it’s a platform for education, legislative news, and medical breakthroughs. As of 2025, UNCOVERED will serve as MBCGA’s flagship communication vehicle, supported by the editorial expertise of the NY Cancer Resource Alliance.  “The new role allows me to bring in clinical voices that can make a real difference,” said Dr. Bard. “There’s tremendous value in collaborative medicine—oncologists, radiologists, and even functional medicine practitioners have a seat at this table.”

Dr. Bard’s vision is deeply international. With past speaking engagements in Amsterdam, Paris, Vienna, Stratford-upon-Avon, and upcoming roles in The Hague, Montreal, and Milan, he carries MBCGA’s mission across borders. His appointment underscores the alliance's global ambitions and the pressing need to break stigmas around male breast cancer in every culture.

WHERE IT ALL STARTED (archive news) By: IPHA News Editor FOR IMMEDIATE RELEASE April 30, 2019 | Brooklyn, NY FDNY Retired Members Association Champions Cancer Awareness for First Responders   In a powerful and emotional gathering focused on post-9/11 health challenges, the Retired Members Association of the FDNY (RMA) hosted a compelling cancer awareness event, drawing a packed audience of career firefighters and medical advocates. This initiative marked the official launch of the First Responders Cancer Resource Team, an RMA-driven effort committed to confronting the silent epidemic of cancer among first responders. The program spotlighted critical topics such as early detection, preventive strategies, and the life-saving importance of seeking a second medical opinion. Underscoring the urgency of the message, Dr. Robert Bard, leading oncological imaging specialist and head clinical advisor for the initiative, made a surprise appearance. In his address, Dr. Bard emphasized the long-term health repercussions faced by 9/11 first responders and reaffirmed his support for the RMA’s proactive health directive.  One of the event’s most stirring moments came from Ms. Cheri Ambrose, dedicated NYCRA First Responder volunteer and president of the Male Breast Cancer Global Alliance. A tireless public advocate for cancer education, Ms. Ambrose passionately addressed what she calls the “invisible barrier” in public health: denial. “Denial is the deadliest delay,” she stated, urging the audience to take charge of their health. She proudly embraced her role in inspiring the urgent tone behind the group’s rallying cry: “Get Checked Now!” This landmark event underscored the RMA’s unwavering commitment to protecting those who once protected us, by fostering education, dialogue, and timely intervention in the fight against occupational cancers. (See complete article + also see PR NEWSWIRE for complete press release).

A GLOBAL VISION FOR EARLY DETECTION
Looking ahead, Dr. Bard envisions MBCGA-certified scanning centers across the U.S. and eventually worldwide. These centers would not only perform male breast cancer screenings but also offer education to other radiology facilities through turnkey programs developed by his team.

“This initiative is scalable,” Bard said. “We’re working to create educational packages that allow other institutions to replicate our diagnostic model. Our goal is not just to treat, but to teach—because awareness is as powerful as any treatment.”

Dr. Bard’s new appointment marks a significant moment in the journey of male breast cancer awareness. His deep ties in both the clinical and advocacy communities promise to reshape the diagnostic landscape for men at risk. Together with MBCGA, Dr. Bard is setting a new global standard—one where no one is left unseen, unheard, or undiagnosed.

 

For more information about the MALE BREAST CANCER GLOBAL ALLIANCE PREDISPOSITION TESTING PROGRAM, contact us at: www.mbcglobalalliance.org or contact our hotline at: 516.522-0777

 --------------------------------------------------------------------------------------------------------------------------

 FOR IMMEDIATE RELEASE

Lennard Goetze Appointed National Cancer Community Outreach Director

May 5, 2025 – The Male Breast Cancer Global Alliance (MBCGA) proudly announces the appointment of Lennard Goetze as its new National Cancer Community Outreach Director. A veteran in executive fundraising, strategic partnerships, and public advocacy, Mr. Goetze brings more than 30 years of distinguished leadership to this growing mission.

Lennard's impressive career includes pivotal roles in nationwide cancer initiatives, including the Leukemia & Lymphoma Society, the 9/11 CancerScan Project, Firefighters Against Cancer Exposures, LI2DAY, the Are You Dense? Foundation and the New York Cancer Resource Alliance. His passion for advocacy is matched by a track record of building cross-sector alliances and mobilizing influential networks.

Leading MBCGA’s Vision for 2025 and Beyond: “Lennard’s work has always inspired me,” says Cheri Ambrose, President and CEO of MBCGA. “Our 2025 leadership team is a dynamic force of professionals and visionaries, and having Lennard on board marks a bold step forward. His ability to unite thought leaders and champion cause-driven action will bring fresh momentum to our mission.”

A Legacy of Networking and Action: Renowned for his expertise in alliance-building, Mr. Goetze has dedicated much of his career to connecting professionals across industries. His early outreach efforts in 2001 focused on supporting firefighters affected by post-9/11 toxic exposures—an experience that helped cement his lifelong commitment to cancer awareness and prevention. His mastery of modern communication platforms, including LinkedIn, has furthered his reputation as a sought-after connector and advocate in the cancer care community.

Fueling MBCGA’s 2025 Expansion- In his new role, Lennard is tasked with spearheading MBCGA’s next phase of growth, including strategic development of educational programs, publishing initiatives, research partnerships, and outreach alliances.

He joins forces with internationally acclaimed imaging expert Dr. Robert L. Bard, who recently unveiled a 10-year retrospective of his groundbreaking work in rare cancer diagnostics using advanced ultrasound technologies (TheCancerDetective.org). Lennard Goetze’s appointment also strengthens collaboration with MBCGA’s Cancer Advisory Committee, which includes some of the top distinguished professionals in cancer care.

The complete list of cancer advisors is available at www.mbcglobalalliance.org.

A Global Call to Action - As MBCGA enters a transformative era, its mission expands beyond borders. With Lennard leading outreach initiatives and a coalition of respected medical leaders driving research and education, the organization is launching a series of international collaborations to elevate male breast cancer awareness on a global stage. Central to this effort is a renewed focus on leveraging social media platforms and digital networks to break the silence, dispel the stigma, and engage the public with facts, faces, and survivor stories. MBCGA’s 2025 campaign underscores a clear message: male breast cancer is real, it is urgent, and together—with visibility and voices—we will bring change.

-------------------------------------------------------------------------------------------------------------------------

THIS MESSAGE IS BROUGHT TO YOU BY THE MALE BREAST CANCER GLOBAL ALLIANCE

The Male Breast Cancer Global Alliance (MBCGA) is leading the charge in awareness, education, and support for men affected by this disease. This organization has built a worldwide network of survivors, advocates, researchers, and healthcare professionals working to shatter the stigma and silence surrounding male breast cancer. They’ve played a crucial role in pushing for more inclusive research, advancing public health messaging, and ensuring men have access to the resources they need. Through tireless advocacy and collaboration, MBCGA has helped get male breast cancer recognized in global cancer policy and has elevated the voices of countless survivors. Their data-driven campaigns and survivor-led storytelling have reached millions, and their partnership with Bard Diagnostics is all about scaling that impact through accessible genetic testing.

  --------------------------------------------------------------------------------------------------------------------------

RELATED RESOURCES

Under a dedicated partnership with the Male Breast Cancer Global Alliance, BARDDIAGNOSTICS established key programs including: EARLIER DETECTION, PREDISPOSITION GENE TESTING, FIGHT RECURRENCE, ACTIVE SURVEILLANCE AND THE 2ND OPINION SCAN. For the many MEN who seek a significantly improved lifestyle or an upgrade in personalized healthcare, getting better answers about your state of health is paramount and IT ALL STARTS WITH STATE OF THE ART DIAGNOSTICS. The visionary paradigm that makes up true personalized medical care involves the integration between modalities, a collaboration between specialists and an upgrade in their strategic approach and you'll find it all at BardDiagnostics. 

 --------------------------------------------------------------------------------------------------------------------------

UNCOVERED – Shedding Light on Male Breast Cancer
The first official newsletter from the Male Breast Cancer Global Alliance, launched in proud partnership with AngioMedical Media and the Integrative Cancer Resource Society. Rooted in the belief that education is power, UNCOVERED delivers essential news, scientific updates, and survivor stories to inform and inspire. Each issue is packed with the latest in male breast cancer research, treatment innovations, and advocacy efforts from around the globe. Whether you're a patient, caregiver, or medical professional, UNCOVERED is your trusted source for facts and forward-thinking perspectives. Join us in uncovering the truth—and empowering lives through knowledge. (visit our regularly updated Newsletter)

 --------------------------------------------------------------------------------------------------------------------------

The INTEGRATIVE CANCER RESOURCE SOCIETY is a self-funded (Linkedin Based) independent volunteer group of non-profit foundations/charities, researchers, educators, community leaders and survivors. Under the spirit of collaboration and partnership, we are joined to bring a new level of support to cancer patients, survivors and all those seeking current information about cancer care. We form a unique network of support for one another- while driven to help those who need additional resources, technical updates or empowerment on the road to recovery. ICRS uses the power of the "interweb" to reach a global audience and a network of resources beyond our local borders. We have engaged some of the most impressive minds, perspectives and resources and enjoyed the exchange of vital information that is useful to all. Thanks in part to digital collaboration, these "foreign" connections have always been a part of our cancer crusade, now joining us in what we call "BORDERLESS MEDICINE".

 --------------------------------------------------------------------------------------------------------------------------

In great support of a the global movement of NON-INVASIVE medicine, we proudly introduce the INTEGRATIVE HEALTH RESEARCH CENTER by AngioInnovation Research (501c3). This New York city-based diagnostic imaging validation lab is established to clinically identify the efficacy, performance and supportive claims set by non-invasive therapeutics and diagnostic solutions. Co-founded by Dr. Robert L. Bard, the IHRC offers a non-profit, non-commercialized testing option for health-related innovations who seek an independent and impartial reporting through single-case pilot studies or IRB-Based clinical trials. The IHRC employs credentialed medical professionals and specialists in clinical research whose experience contributes to the unique strategic approach of each test study. (Visit: the AngioInstitute website)

Disclaimer & Copyright Notice: The materials provided on this web-based article are copyrighted and the intellectual property of the publishers/producers (The MBC Global Alliance). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

The information provided in this article is a compiled report from public websites whose links are listed in the FOOTNOTES OR REFERENCE section and the statements and quotes included are from actual interviews by those whose names are stated who provided express consent to the publishing of this material.  This article is not meant to be used to diagnose, treat or advise others about what actions they should take with regard to any medical condition.  No one should undertake or discontinue any treatment as a result of what they read on our blogs. The publisher(s), editors or sponsors  are providing a strictly educational or editorial service and are not responsible for the diagnosis or treatment of any specific health needs. Writers and publishers are not liable for any damages or negative consequences from any treatment, action, application or preparation to any person(s) reading the information in this article or its thread. Readers with medical needs should obtain appropriate professional medical supervision. References are provided for any informational purposes only and do not constitute endorsement of any websites or other sources.